Try our Advanced Search for more refined results

Anthony Basile et al v. Valeant Pharmaceutical International, Inc. et al

  1. October 12, 2016

    Allergan Investors Urge Class Cert. In Insider Trading Row

    Allergan investors accusing Valeant Pharmaceuticals of unlawfully tipping off hedge fund Pershing Square about an unsolicited $55 billion takeover bid of Allergan asked a California federal judge Tuesday to grant the suit class action status, saying they were harmed by the alleged insider trading scheme.

  2. July 27, 2016

    Bernstein Litowitz Rips Subpoena In Insider Trading Row

    Bernstein Litowitz Berger & Grossmann LLP, which represents investors alleging that Valeant Pharmaceuticals International Inc. illegally tipped Pershing Square Capital Management LP to a proposed merger, urged a California federal judge on Tuesday to reject Pershing's subpoena, calling it a bid to "distract" the firm.

  3. November 11, 2015

    Valeant Can't Dodge Insider Trading Row Over Allergan Bid

    A California federal judge on Monday refused to dismiss an insider trading lawsuit brought by two pension funds claiming Valeant Pharmaceuticals International Inc. illegally fed Pershing Square Capital Management LP inside information about its attempted $55 billion takeover of Allergan Inc., holding the company couldn't escape claims on the grounds it used a broker.

  4. September 21, 2015

    Investors Slam Valeant's Bid To Duck Insider Trading Suit

    Two pension funds claiming Valeant Pharmaceuticals International Inc. illegally fed Pershing Square Capital Management LP inside information about its attempted $55 billion takeover of Allergan Inc. told a California federal court Friday that Valeant's dismissal arguments have already been rejected or don't hold up to close scrutiny.

  5. July 09, 2015

    Securities Cases To Watch In The 2nd Half Of 2015

    Like the first half of the year, the second half of 2015 will likely be marked by lingering fallout from the Second Circuit's landmark Newman decision and a Georgia judge's decision to block a U.S. Securities and Exchange Commission in-house case, but that's not all to watch out for. Here, Law360 takes a look at the securities litigation landscape for the rest of the year.

  6. May 07, 2015

    Bernstein Litowitz To Co-Lead Allergan Investor Suit

    Bernstein Litowitz Berger & Grossmann LLP and another firm prevailed Tuesday over​ ​rival firms vying to lead a shareholder lawsuit in California federal court rooted in Valeant Pharmaceutical International Inc.'s aborted $55 billion takeover of Allergan PLC.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!